ProPhase Labs, Inc. Capital Expenditures
ProPhase Labs, Inc. (PRPH) reported Capital Expenditures of $73.00 thousand for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-12.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2019-08-12
- ProPhase Labs, Inc. payments to acquire property, plant, and equipment for the quarter ending 2019-06-30 was $25.00K.
- ProPhase Labs, Inc. payments to acquire property, plant, and equipment for the quarter ending 2019-03-31 was $48.00K.
- ProPhase Labs, Inc. payments to acquire property, plant, and equipment for the quarter ending 2018-12-31 was $116.00K, a 1833.33% increase year-over-year.
- ProPhase Labs, Inc. payments to acquire property, plant, and equipment for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- ProPhase Labs, Inc. payments to acquire property, plant, and equipment for fiscal 2018 was $140.00K, a 32.69% decline from fiscal 2017.
- ProPhase Labs, Inc. payments to acquire property, plant, and equipment for fiscal 2017 was $208.00K, a 68.05% decline from fiscal 2016.
- ProPhase Labs, Inc. payments to acquire property, plant, and equipment for fiscal 2016 was $651.00K, a 9.33% decline from fiscal 2015.
- ProPhase Labs, Inc. payments to acquire property, plant, and equipment for fiscal 2015 was $718.00K, a 130.13% increase from fiscal 2014.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2019-06-30 | $25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $73.00K 10-Q · filed 2019-08-12 | $189.00K derived: sum of 3 quarters · filed 2019-08-12 | $189.00K derived: sum of 4 quarters · filed 2019-08-12 |
| 2019-03-31 | $48.00K 10-Q · filed 2019-05-14 | $164.00K derived: sum of 2 quarters · filed 2019-05-14 | $164.00K derived: sum of 3 quarters · filed 2019-05-14 | |
| 2018-12-31 | $116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $116.00K derived: sum of 2 quarters · filed 2019-03-26 | $140.00K 10-K · filed 2019-03-26 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $24.00K 10-Q · filed 2018-11-14 | ||
| 2018-06-30 | $24.00K 10-Q · filed 2019-08-12 | |||
| 2017-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $76.00K derived: sum of 2 quarters · filed 2019-03-26 | $166.00K derived: sum of 3 quarters · filed 2019-03-26 | $208.00K 10-K · filed 2019-03-26 |
| 2017-09-30 | $70.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2018-11-14 | $160.00K derived: sum of 2 quarters · filed 2018-11-14 | $202.00K 10-Q · filed 2018-11-14 | $434.00K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $90.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-08-20 | $132.00K 10-Q/A · filed 2018-08-20 | $364.00K derived: sum of 3 quarters · filed 2018-08-20 | $456.00K derived: sum of 4 quarters · filed 2018-08-20 |
| 2017-03-31 | $42.00K 10-Q/A · filed 2018-08-20 | $274.00K derived: sum of 2 quarters · filed 2018-08-20 | $366.00K derived: sum of 3 quarters · filed 2018-08-20 | $483.00K derived: sum of 4 quarters · filed 2018-08-20 |
| 2016-12-31 | $232.00K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-08-20 | $324.00K derived: sum of 2 quarters · filed 2018-08-20 | $441.00K derived: sum of 3 quarters · filed 2018-08-20 | $651.00K 10-K/A · filed 2018-08-20 |
| 2016-09-30 | $92.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-08-20 | $209.00K derived: sum of 2 quarters · filed 2018-08-20 | $419.00K 10-Q/A · filed 2018-08-20 | $459.00K derived: sum of 4 quarters · filed 2018-08-20 |
| 2016-06-30 | $117.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-08-20 | $327.00K 10-Q/A · filed 2018-08-20 | $367.00K derived: sum of 3 quarters · filed 2018-08-20 | $617.00K derived: sum of 4 quarters · filed 2018-08-20 |
| 2016-03-31 | $210.00K 10-Q/A · filed 2018-08-20 | $250.00K derived: sum of 2 quarters · filed 2018-08-20 | $500.00K derived: sum of 3 quarters · filed 2018-08-20 | $886.00K derived: sum of 4 quarters · filed 2018-08-20 |
| 2015-12-31 | $40.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-08-20 | $290.00K derived: sum of 2 quarters · filed 2018-08-20 | $676.00K derived: sum of 3 quarters · filed 2018-08-20 | $718.00K 10-K/A · filed 2018-08-20 |
| 2015-09-30 | $250.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $636.00K derived: sum of 2 quarters · filed 2016-11-14 | $678.00K 10-Q · filed 2016-11-14 | $868.00K derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-06-30 | $386.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $428.00K 10-Q · filed 2016-08-11 | $618.00K derived: sum of 3 quarters · filed 2017-02-24 | $662.00K derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-03-31 | $42.00K 10-Q · filed 2016-05-13 | $232.00K derived: sum of 2 quarters · filed 2017-02-24 | $276.00K derived: sum of 3 quarters · filed 2017-02-24 | $337.00K derived: sum of 4 quarters · filed 2017-02-24 |
| 2014-12-31 | $190.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $234.00K derived: sum of 2 quarters · filed 2017-02-24 | $295.00K derived: sum of 3 quarters · filed 2017-02-24 | $312.00K 10-K · filed 2017-02-24 |
| 2014-09-30 | $44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $105.00K derived: sum of 2 quarters · filed 2015-11-13 | $122.00K 10-Q · filed 2015-11-13 | $240.00K derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-06-30 | $61.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $78.00K 10-Q · filed 2015-08-12 | $196.00K derived: sum of 3 quarters · filed 2016-03-29 | $270.00K derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-03-31 | $17.00K 10-Q · filed 2015-05-13 | $135.00K derived: sum of 2 quarters · filed 2016-03-29 | $209.00K derived: sum of 3 quarters · filed 2016-03-29 | $451.00K derived: sum of 4 quarters · filed 2016-03-29 |
| 2013-12-31 | $118.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $192.00K derived: sum of 2 quarters · filed 2016-03-29 | $434.00K derived: sum of 3 quarters · filed 2016-03-29 | $442.00K 10-K · filed 2016-03-29 |
| 2013-09-30 | $74.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $316.00K derived: sum of 2 quarters · filed 2014-11-13 | $324.00K 10-Q · filed 2014-11-13 | $301.00K derived: sum of 4 quarters · filed 2015-03-27 |
| 2013-06-30 | $242.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $250.00K 10-Q · filed 2014-08-12 | $227.00K derived: sum of 3 quarters · filed 2015-03-27 | $328.00K derived: sum of 4 quarters · filed 2015-03-27 |
| 2013-03-31 | $8.00K 10-Q · filed 2014-05-12 | -$15.00K derived: sum of 2 quarters · filed 2015-03-27 | $86.00K derived: sum of 3 quarters · filed 2015-03-27 | $270.00K derived: sum of 4 quarters · filed 2015-03-27 |
| 2012-12-31 | -$23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $78.00K derived: sum of 2 quarters · filed 2015-03-27 | $262.00K derived: sum of 3 quarters · filed 2015-03-27 | $310.00K 10-K · filed 2015-03-27 |
| 2012-09-30 | $101.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $285.00K derived: sum of 2 quarters · filed 2013-11-13 | $333.00K 10-Q · filed 2013-11-13 | $345.00K derived: sum of 4 quarters · filed 2014-03-27 |
| 2012-06-30 | $184.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | $232.00K 10-Q · filed 2013-08-13 | $244.00K derived: sum of 3 quarters · filed 2014-03-27 | $328.00K derived: sum of 4 quarters · filed 2014-03-27 |
| 2012-03-31 | $48.00K 10-Q · filed 2013-05-10 | $60.00K derived: sum of 2 quarters · filed 2014-03-27 | $144.00K derived: sum of 3 quarters · filed 2014-03-27 | $338.00K derived: sum of 4 quarters · filed 2014-03-27 |
| 2011-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $96.00K derived: sum of 2 quarters · filed 2014-03-27 | $290.00K derived: sum of 3 quarters · filed 2014-03-27 | $300.00K 10-K · filed 2014-03-27 |
| 2011-09-30 | $84.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $278.00K derived: sum of 2 quarters · filed 2012-11-14 | $288.00K 10-Q · filed 2012-11-14 | $295.00K derived: sum of 4 quarters · filed 2013-03-28 |
| 2011-06-30 | $194.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | $204.00K 10-Q · filed 2012-08-13 | $211.00K derived: sum of 3 quarters · filed 2013-03-28 | $241.00K derived: sum of 4 quarters · filed 2013-03-28 |
| 2011-03-31 | $10.00K 10-Q · filed 2012-05-11 | $17.00K derived: sum of 2 quarters · filed 2013-03-28 | $47.00K derived: sum of 3 quarters · filed 2013-03-28 | |
| 2010-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $37.00K derived: sum of 2 quarters · filed 2013-03-28 | $153.00K 10-K · filed 2013-03-28 | |
| 2010-09-30 | $30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $146.00K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $116.00K 10-Q · filed 2011-08-12 | |||
| 2009-12-31 | $208.00K 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |